Search Orphan Drug Designations and Approvals
-
| Generic Name: | Gonadorelin acetate | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | Lutrepulse | ||||||||||||||||
| Date Designated: | 04/22/1987 | ||||||||||||||||
| Orphan Designation: | For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion. | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Ferring Laboratories, Inc. 400 Rella Boulevard, Suite 201 Suffern, New York 10901 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | Gonadorelin acetate |
|---|---|---|
| Trade Name: | Lutrepulse | |
| Marketing Approval Date: | 10/10/1989 | |
| Approved Labeled Indication: | ||
| Exclusivity End Date: | 10/10/1996 | |
| Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







